FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Levothyroxine sodium anhydrous 75 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Levothyroxine sodium anhydrous 75 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Levothyroxine sodium anhydrous 100 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Levothyroxine sodium anhydrous 100 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lofepramine (as lofepramine hydrochloride) 70 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lofepramine (as lofepramine hydrochloride) 70 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Quinagolide (as quinagolide hydrochloride) 75 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Quinagolide (as quinagolide hydrochloride) 75 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Salbutamol (as salbutamol sulfate) 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Salbutamol (as salbutamol sulfate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Pergolide (as pergolide mesilate) 250 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Pergolide (as pergolide mesilate) 250 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Reboxetine (as reboxetine mesilate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Reboxetine (as reboxetine mesilate) 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 2
Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Darunavir (as darunavir ethanolate) 600 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Darunavir (as darunavir ethanolate) 600 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Fenoprofen (as fenoprofen calcium) 300 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Fenoprofen (as fenoprofen calcium) 300 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Levothyroxine sodium anhydrous 50 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Levothyroxine sodium anhydrous 50 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some

Start Previous Page 57 of 81 Next End


This concept is not in any reference sets

Back to Start